Amylyx Pharmaceuticals Inc (AMLX)

Total Costs & Expenses

$162.10M

TTM · Period ending: · USD

AMLX logo

AMLX Total Costs & Expenses

Latest reported$162.10M
AMLX TTM Total Costs & Expenses ($62.97M → $162.10M)
High-resolution chart · PNG

AMLX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amylyx Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
162,104,000
159,268,000
153,292,000
156,676,000
196,726,000
206,281,000
379,251,000
445,777,000
453,673,000
479,276,000
341,984,000
301,947,000
273,000,000
249,238,000
223,571,000
185,408,000
153,300,000
117,634,000
82,688,000
62,965,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.